291 related articles for article (PubMed ID: 30574930)
1.
Ozdemir HB; Özmen MC; Aktas Z; Hasanreisoglu M
Indian J Ophthalmol; 2019 Jan; 67(1):153-155. PubMed ID: 30574930
[TBL] [Abstract][Full Text] [Related]
2. A New Viscous Cysteamine Eye Drops Treatment for Ophthalmic Cystinosis: An Open-Label Randomized Comparative Phase III Pivotal Study.
Liang H; Labbé A; Le Mouhaër J; Plisson C; Baudouin C
Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2275-2283. PubMed ID: 28426870
[TBL] [Abstract][Full Text] [Related]
3. In vivo confocal microscopy and anterior segment optical coherence tomography analysis of the cornea in nephropathic cystinosis.
Labbé A; Niaudet P; Loirat C; Charbit M; Guest G; Baudouin C
Ophthalmology; 2009 May; 116(5):870-6. PubMed ID: 19410944
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of topical cysteamine in nephropathic cystinosis.
Al-Hemidan A; Shoughy SS; Kozak I; Tabbara KF
Br J Ophthalmol; 2017 Sep; 101(9):1234-1237. PubMed ID: 28057644
[TBL] [Abstract][Full Text] [Related]
5. Photophobia and corneal crystal density in nephropathic cystinosis: an in vivo confocal microscopy and anterior-segment optical coherence tomography study.
Liang H; Baudouin C; Tahiri Joutei Hassani R; Brignole-Baudouin F; Labbe A
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3218-25. PubMed ID: 26024106
[TBL] [Abstract][Full Text] [Related]
6. Ocular manifestations of intermediate cystinosis: To treat or not to treat?
Sousa-Neves F; Ribeiro AC; Saraiva E; Ribeiro L; Sequeira J; Varandas R
Eur J Ophthalmol; 2020 Nov; 30(6):NP7-NP10. PubMed ID: 31074291
[TBL] [Abstract][Full Text] [Related]
7. Examination of corneal deposits in nephropathic cystinosis using in vivo confocal microscopy and anterior segment optical coherence tomography: an age-dependent cross sectional study.
Csorba A; Maka E; Maneschg OA; Szabó A; Szentmáry N; Csidey M; Resch M; Imre L; Knézy K; Nagy ZZ
BMC Ophthalmol; 2020 Feb; 20(1):73. PubMed ID: 32102651
[TBL] [Abstract][Full Text] [Related]
8. [Ocular treatment of cystinosis with eye drop containing cysteamine].
Csorba A; Maka E; Szabó A; Kelen K; Reusz G; Nagy ZZ
Orv Hetil; 2022 May; 163(21):846-852. PubMed ID: 35598215
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of treatment with cysteamine eyedrops for cystinosis with confocal microscopy.
Tavares R; Coelho D; Macário MC; Torres A; Quadrado MJ; Murta J
Cornea; 2009 Sep; 28(8):938-40. PubMed ID: 19654516
[TBL] [Abstract][Full Text] [Related]
10. A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: the Cystadrops OCT-1 study.
Labbé A; Baudouin C; Deschênes G; Loirat C; Charbit M; Guest G; Niaudet P
Mol Genet Metab; 2014 Mar; 111(3):314-320. PubMed ID: 24440466
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Topical Cysteamine in Corneal Cystinosis: A Systematic Review and Meta-Analysis.
Kaur S; Sarma P; Kaur H; Prajapat M; Shekhar N; Bhattacharyya J; Kaur H; Kumar S; Medhi B; Ram J; Das D; Avti P; Prakash A; Singh R; Bhattacharyya A
Am J Ophthalmol; 2021 Mar; 223():275-285. PubMed ID: 32888903
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Scheimpflug Corneal Tomography and Anterior Segment Optical Coherence Tomography Measurements in Corneal Cystinosis: A Case Series.
Vercauteren L; Consejo A; De Vries MJ; Krolo I; Koppen C; Ní Dhubhghaill S
Eye Contact Lens; 2024 Jul; 50(7):321-328. PubMed ID: 38630953
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of topical cysteamine therapy in the CTNS(-/-) knockout mouse using in vivo confocal microscopy.
Simpson JL; Nien CJ; Flynn KJ; Jester JV
Mol Vis; 2011; 17():2649-54. PubMed ID: 22065917
[TBL] [Abstract][Full Text] [Related]
14. Establishing an objective biomarker for corneal cystinosis using a threshold-based Spectral domain optical coherence tomography imaging algorithm.
Keidel L; Elhardt C; Hohenfellner K; Priglinger S; Schworm B; Wertheimer C; Priglinger C; Luft N
Acta Ophthalmol; 2021 Mar; 99(2):e189-e195. PubMed ID: 32833325
[TBL] [Abstract][Full Text] [Related]
15. Nephropathic cystinosis in children: An overlooked disease.
Soliman NA; El-Baroudy R; Rizk A; Bazaraa H; Younan A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):436-42. PubMed ID: 19414947
[TBL] [Abstract][Full Text] [Related]
16. Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops.
Gahl WA; Kuehl EM; Iwata F; Lindblad A; Kaiser-Kupfer MI
Mol Genet Metab; 2000; 71(1-2):100-20. PubMed ID: 11001803
[TBL] [Abstract][Full Text] [Related]
17. A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis.
Iwata F; Kuehl EM; Reed GF; McCain LM; Gahl WA; Kaiser-Kupfer MI
Mol Genet Metab; 1998 Aug; 64(4):237-42. PubMed ID: 9758713
[TBL] [Abstract][Full Text] [Related]
18. [Cysteamine eyedrops for treatment of corneal cysteine deposits in infantile cystinosis].
Gräf M; Grote A; Wagner F
Klin Monbl Augenheilkd; 1992 Jul; 201(1):48-50. PubMed ID: 1513127
[TBL] [Abstract][Full Text] [Related]
19. Removal of corneal crystals by topical cysteamine in nephropathic cystinosis.
Kaiser-Kupfer MI; Fujikawa L; Kuwabara T; Jain S; Gahl WA
N Engl J Med; 1987 Mar; 316(13):775-9. PubMed ID: 3821824
[TBL] [Abstract][Full Text] [Related]
20. In vivo confocal microscopy of the cornea in nephropathic cystinosis.
Grupcheva CN; Ormonde SE; McGhee C
Arch Ophthalmol; 2002 Dec; 120(12):1742-5. PubMed ID: 12470153
[No Abstract] [Full Text] [Related]
[Next] [New Search]
